NASDAQ:HSCS Heart Test Laboratories (HSCS) Stock Price, News & Analysis → Major Elon Musk Crypto Leak Revealed (From Crypto 101 Media) (Ad) Free HSCS Stock Alerts $0.12 0.00 (0.00%) (As of 03/28/2024 ET) Add Compare Share Share Today's Range$0.11▼$0.1250-Day Range$0.12▼$0.1852-Week Range$0.11▼$1.49Volume1.46 million shsAverage Volume2.86 million shsMarket Capitalization$7.66 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial Media Get Heart Test Laboratories alerts: Email Address Ad Crypto 101 MediaSHOCKING Crypto Leak…A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024. Claim your free seat by clicking here now. About Heart Test Laboratories Stock (NASDAQ:HSCS)Heart Test Laboratories, Inc., a medical technology company, provides cardiovascular diagnostic devices. The company offers MyoVista wavECG, a resting 12-lead electrocardiograph (ECG) to provide diagnostic information related to cardiac dysfunction, as well as conventional ECG information. It serves clinics, doctor's offices, urgent care centers, and hospitals. The company was incorporated in 2007 and is headquartered in Southlake, Texas.Read More HSCS Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart HSCS Stock News HeadlinesMarch 26, 2024 | globenewswire.comHeartSciences Announces Podium Presentation at World Congress of Anesthesiologists on the Utility of MyoVista® Wavelet ECG For Detection of Left Ventricular Diastolic Dysfunction in Preoperative PatientsMarch 15, 2024 | finanznachrichten.deHeart Test Laboratories, Inc.: HeartSciences Reports Third Quarter Fiscal 2024 Financial ResultsMarch 29, 2024 | DTI (Ad)the most reliable asset on earth is making a comebackGlobal tensions have been pushing the price of gold to all time highs… Just recently, gold peaked at a record $2,000 (and is now closer to $2,200). And there’s something else critical at play right now in the world’s largest asset. Because of these critical factors, a lot of massive investment institutions are now pumping more money into gold. And as we speak, some are even calling for a massive rally in the precious metal.March 14, 2024 | benzinga.comRecap: Heart Test Laboratories Q3 EarningsMarch 14, 2024 | finance.yahoo.comHeartSciences Reports Third Quarter Fiscal 2024 Financial ResultsMarch 14, 2024 | globenewswire.comHeartSciences Reports Third Quarter Fiscal 2024 Financial ResultsMarch 12, 2024 | morningstar.comHeart Test Laboratories IncMarch 12, 2024 | finance.yahoo.comHeartSciences’ Announces Peer-Reviewed Publication Evaluating Use of MyoVista® Technology to Detect Asymptomatic Left Ventricular Dysfunction in Patients with Type 2 DiabetesMarch 29, 2024 | WealthPress (Ad)A lot of people are making this costly mistakeYou may have heard the saying “options are risky” … And, they can be. But only if you use them the way a lot of folks do. A lot of people think of BUYING speculative options when they talk about options. And BUYING low probability, speculative options is definitely risky… It’s how some folks leverage large sums of money hoping that a stock moves in the “right” direction over a certain period of time. March 12, 2024 | globenewswire.comHeartSciences' Announces Peer-Reviewed Publication Evaluating Use of MyoVista® Technology to Detect Asymptomatic Left Ventricular Dysfunction in Patients with Type 2 DiabetesMarch 6, 2024 | investorplace.comWhy Is Heart Test Laboratories (HSCS) Stock Down 21% Today?March 6, 2024 | globenewswire.comHeartSciences Announces Canada Patent Grant Covering MyoVista® Wavelet TechnologyFebruary 26, 2024 | globenewswire.comHeartSciences Adds Key Advisor to its Scientific Advisory BoardFebruary 24, 2024 | forbes.comBest At-Home Blood Tests: A 2024 GuideFebruary 12, 2024 | finance.yahoo.comHeartSciences Expands its Scientific Advisory BoardFebruary 2, 2024 | msn.com'Heart-on-a-chip' to test chemotherapies and other cancer drugs for heart toxicityFebruary 1, 2024 | msn.comPromising heart drugs identified by cutting-edge combo of machine learning, human learningDecember 20, 2023 | investing.comHeart Test Laboratories Unt (HSCS) Earnings Dates & ReportsDecember 15, 2023 | finanznachrichten.deHeart Test Laboratories, Inc.: HeartSciences Reports Second Quarter Fiscal 2024 Financial ResultsNovember 21, 2023 | benzinga.comThinking about buying stock in Devon Energy, NextEra Energy, Datadog, Heart Test Laboratories, or Artivion?November 20, 2023 | finance.yahoo.comHeartSciences Announces Closing of License Agreements with the Icahn School of Medicine at Mount Sinai to Develop and Commercialize AI Cardiovascular AlgorithmsOctober 19, 2023 | finance.yahoo.comHeartSciences Issues Investor Update Highlighting Recent Key Achievements and Positive DevelopmentsSeptember 25, 2023 | finance.yahoo.comHeartSciences to Participate in the Maxim Group Virtual Tech Conference Series: Emerging Growth in A.I.September 21, 2023 | finance.yahoo.comHeartSciences Signs Definitive Agreements with the Icahn School of Medicine at Mount Sinai to Commercialize Artificial Intelligence Cardiovascular AlgorithmsSeptember 14, 2023 | finance.yahoo.comHeartSciences Reports First Quarter Fiscal 2024 Financial ResultsSeptember 11, 2023 | finance.yahoo.comHeartSciences Named Electrocardiography Advancement Specialists of the Year 2023 - USA in the Global Health & Pharma Excellence AwardsAugust 31, 2023 | finance.yahoo.comHeartSciences Signs Distribution Agreement with FJ Medical, DenmarkSee More Headlines Receive HSCS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Heart Test Laboratories and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings12/14/2023Today3/28/2024Fiscal Year End4/30/2024Next Earnings (Estimated)7/16/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Medical Devices Sub-IndustryN/A Current SymbolNASDAQ:HSCS CUSIPN/A CIK1468492 Webheartsciences.com Phone682-237-7781FaxN/AEmployees12Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($0.48) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-6,350,000.00 Net MarginsN/A Pretax Margin-33,636.84% Return on Equity-381.92% Return on Assets-134.17% Debt Debt-to-Equity RatioN/A Current Ratio5.09 Quick Ratio4.70 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value$0.13 per share Price / Book0.90Miscellaneous Outstanding Shares65,560,000Free Float63,779,000Market Cap$7.66 million OptionableNot Optionable Beta3.44 (Almost) Everything You Need To Know About The EV MarketClick the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise. Get This Free Report Key ExecutivesMr. Andrew Simpson (Age 54)CEO, President & Chairman of the Board of Directors Comp: $264.14kMs. Danielle Watson (Age 41)CFO & Treasurer Comp: $188.75kMr. Mark T. Hilz (Age 65)COO, Secretary & Director Comp: $263.61kKey CompetitorsPredictive OncologyNASDAQ:POAINutribandNASDAQ:NTRBProtagenic TherapeuticsNASDAQ:PTIXPlus TherapeuticsNASDAQ:PSTVAquaBounty TechnologiesNASDAQ:AQBView All CompetitorsInstitutional OwnershipVanguard Group Inc.Bought 175,600 shares on 3/11/2024Ownership: 0.276%Virtu Financial LLCBought 229,762 shares on 2/26/2024Ownership: 0.401%Vanguard Group Inc.Bought 175,600 shares on 2/15/2024Ownership: 0.276%View All Institutional Transactions HSCS Stock Analysis - Frequently Asked Questions How have HSCS shares performed in 2024? Heart Test Laboratories' stock was trading at $0.1710 at the start of the year. Since then, HSCS shares have decreased by 31.6% and is now trading at $0.1169. View the best growth stocks for 2024 here. Are investors shorting Heart Test Laboratories? Heart Test Laboratories saw a increase in short interest in the month of March. As of March 15th, there was short interest totaling 506,000 shares, an increase of 157.9% from the February 29th total of 196,200 shares. Based on an average daily trading volume, of 2,900,000 shares, the days-to-cover ratio is presently 0.2 days. Currently, 1.0% of the shares of the company are sold short. View Heart Test Laboratories' Short Interest. When is Heart Test Laboratories' next earnings date? The company is scheduled to release its next quarterly earnings announcement on Tuesday, July 16th 2024. View our HSCS earnings forecast. How were Heart Test Laboratories' earnings last quarter? Heart Test Laboratories, Inc. (NASDAQ:HSCS) posted its quarterly earnings results on Thursday, December, 14th. The company reported ($0.16) earnings per share for the quarter, missing analysts' consensus estimates of ($0.12) by $0.04. When did Heart Test Laboratories IPO? Heart Test Laboratories (HSCS) raised $9 million in an initial public offering (IPO) on Wednesday, June 15th 2022. The company issued 1,800,000 shares at a price of $4.50-$5.50 per share. The Benchmark Company served as the underwriter for the IPO. Who are Heart Test Laboratories' major shareholders? Heart Test Laboratories' stock is owned by a variety of institutional and retail investors. Top institutional investors include Virtu Financial LLC (0.40%), Vanguard Group Inc. (0.28%) and Vanguard Group Inc. (0.28%). How do I buy shares of Heart Test Laboratories? Shares of HSCS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:HSCS) was last updated on 3/29/2024 by MarketBeat.com Staff From Our PartnersDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsTop Project Outperforms BTC in 2023…Crypto 101 MediaMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceAI Cracks Open Largest Untapped Energy Reserve on EarthBanyan Hill PublishingThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading Academy“The Stock Market’s Bull Run is Far from Over” -BarronsVertical Research AdvisoryAI healthcare stock poised for 36,996% growth?Behind the MarketsBill Gates is all about this tiny $2 stockTimothy Sykes Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Heart Test Laboratories, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.